Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice says NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.SummaryDifference0.3%

- Check8 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check15 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check29 days agoChange DetectedThe record history now includes a new Study Status entry added in September 2026. An older history entry from July 2026 was removed.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page history now shows a new site revision v3.7.0, replacing the previous v3.6.6, indicating a software update to the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.6 in the footer, replacing the previous Revision: v3.6.5. This indicates a software update to the site.SummaryDifference0.0%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.